Immunodeficiencies - Medical illustrations and information to support doctor-patient discussions.

HyQvia® treatment is a 10% subcutaneous immunoglobulin treatment facilitated by recombinant human hyaluronidase. Learn more about HyQvia®'s mode of action and why this improves bioavailability. This innovative therapy utilizes a dosage interval every 2-4 weeks.^1,2